A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Clinical trial NCT00216476 · COMPLETED

Trial details

NCT number: NCT00216476
Sponsor: Janssen-Cilag International NV
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Psychotic Disorders

Start date: 2004-10-01
Primary completion: 2007-11-01
Enrollment: 753

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.